PMGC Holdings Inc. (ELAB) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
120 NEWPORT CENTER DRIVE NEWPORT BEACH, CA 92660 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2024 | 12/31/2023 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 3,327 | |||
| Cash and cash equivalent | 3,327 | |||
| Receivables | 36 | |||
| Inventory, net of allowances, customer advances and progress billings | 496 | |||
| Inventory | 496 | |||
| Prepaid expense | ||||
| Asset, held-for-sale, not part of disposal group | ||||
| Deposits current assets | ||||
| Other undisclosed current assets | 1,061 | |||
| Total current assets: | 4,919 | |||
| Noncurrent Assets | ||||
| Operating lease, right-of-use asset | 207 | |||
| Property, plant and equipment | 53 | |||
| Long-term investments and receivables | ||||
| Long-term investments | ||||
| Intangible assets, net (including goodwill) | ||||
| Intangible assets, net (excluding goodwill) | ||||
| Deposits noncurrent assets | 11 | |||
| Total noncurrent assets: | 270 | |||
| TOTAL ASSETS: | 5,190 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities, including: | 669 | |||
| Other undisclosed accounts payable and accrued liabilities | 669 | |||
| Debt | ||||
| Derivative instruments and hedges, liabilities | 369 | |||
| Disposal group, including discontinued operation | ||||
| Other liabilities | 77 | |||
| Other undisclosed current liabilities | 182 | |||
| Total current liabilities: | 1,297 | |||
| Noncurrent Liabilities | ||||
| Liabilities, other than long-term debt | 65 | |||
| Operating lease, liability | 65 | |||
| Other undisclosed noncurrent liabilities | ||||
| Total noncurrent liabilities: | 65 | |||
| Total liabilities: | 1,363 | |||
| Equity | ||||
| Equity, attributable to parent | 3,827 | |||
| Common stock | 2 | |||
| Additional paid in capital | 10,849 | |||
| Accumulated other comprehensive income (loss) | 0 | |||
| Accumulated deficit | (7,024) | |||
| Total equity: | 3,827 | |||
| TOTAL LIABILITIES AND EQUITY: | 5,190 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2024 | 12/31/2023 | ||
|---|---|---|---|
| Revenues | 1,713 | ||
| Cost of revenue | (1,713) | ||
| Other undisclosed gross profit | 1,135 | ||
| Gross profit: | 1,135 | ||
| Operating expenses | |||
| Operating income (loss): | 1,135 | ||
| Nonoperating income (expense) | (3,766) | ||
| Investment income, nonoperating | |||
| Interest and debt expense | (20) | ||
| Loss from continuing operations: | (2,651) | ||
| Loss from discontinued operations | |||
| Net loss: | (2,651) | ||
| Other undisclosed net income (loss) attributable to parent | (1,650) | ||
| Net loss available to common stockholders, diluted: | (4,302) | ||
Comprehensive Income ($ in thousands)
| 12/31/2024 | 12/31/2023 | ||
|---|---|---|---|
| Net loss: | (2,651) | ||
| Comprehensive loss: | (2,651) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (1,650) | ||
| Comprehensive loss, net of tax, attributable to parent: | (4,301) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.